PDE7-IN-3

PDE7-IN-3

• CAS Number: 908570-13-8
• UNSPSC Description: Pde7-in-3 (example 2) is an inhibitor of the phosphodiesterase PDE7 with potential analgesic activity. PDE7-IN-3 can be used to study inflammatory, neuropathic, visceral and nociceptive pain[1].
• Target Antigen: Phosphodiesterase (PDE)
• Type: Reference compound
• Related Pathways: Metabolic Enzyme/Protease
• Applications: COVID-19-immunoregulation
• Field of Research: Inflammation/Immunology; Neurological Disease
• Assay Protocol: https://www.medchemexpress.com/pde7-in-3.html
• Purity: 99.94
• Solubility: DMSO : 100 mg/mL (ultrasonic;warming;heat to 80°C)
• Smiles: O=C1NC2(CCCCC2)C(C(N1)=C3Cl)=C(C=C3)O[C@@H](C4)C[C@H]4C(O)=O
• Molecular Weight: 364.82
• References & Citations: [1]Cox Peter, et al. Use of combinations of PDE7 inhibitors and alpha-2-delta ligands for the treatment of neuropathic pain. World Intellectual Property Organization, WO2006092692 A1. 2006-09-08.
• Shipping Conditions: Room Temperature
• Storage Conditions: -20°C, 3 years; 4°C, 2 years (Powder)
• Clinical Information: No Development Reported